“Geron Starts Phase 3 Clinical Trial in Lower Risk Myelodysplastic Syndromes”

“Geron Starts Phase 3 Clinical Trial in Lower Risk Myelodysplastic Syndromes GlobeNewswire•August 8, 2019″ (https://finance.yahoo.com/news/geron-starts-phase-3-clinical-120800106.html; obtained on 8-8-2019) article began the following way: …

Read more